RT Journal Article
SR Electronic
T1 Ability to detect fake news predicts sub-national variation in COVID-19 vaccine uptake across the UK
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.10.23289764
DO 10.1101/2023.05.10.23289764
A1 Loomba, Sahil
A1 Maertens, Rakoen
A1 Roozenbeek, Jon
A1 Götz, Friedrich M.
A1 van der Linden, Sander
A1 de Figueiredo, Alexandre
YR 2023
UL http://medrxiv.org/content/early/2023/05/14/2023.05.10.23289764.abstract
AB Susceptibility to believing false or misleading information is associated with a range of adverse outcomes. However, it is notoriously difficult to study the link between susceptibility to misinformation and consequential real-world behaviors such as vaccine uptake. In this preregistered study, we devise a large-scale socio-spatial model that combines the rigor of a psychometrically validated test of misinformation susceptibility administered to a nationally representative sample of 16,477 individuals with COVID-19 vaccine uptake data of 129 sub-national regions published by the United Kingdom (UK) government, to show that the general ability to detect misinformation strongly and positively predicts regional vaccine uptake in the UK. We put this practically significant correlational effect size into perspective by noting how psychological interventions that reduce individuals’ misinformation susceptibility could be associated with additional vaccine uptake.Competing Interest StatementThe authors declare the following competing interests: A.d.F. has been involved in Vaccine Confidence Project collaborative grants with Janssen and GlaxoSmithKline over the past two years, has consulted with the Pfizer program on Strengthening Childhood Immunisation Pathways, and was awarded a Merck Investigator Studies Program grant that funded data collection in this study.Funding StatementS.L. was supported by an Engineering and Physical Sciences Research Council (EPSRC) International Doctoral Scholarship. R.M. was supported by the Economic and Social Research Council (ESRC) and the Cambridge Trust (CT). A.d.F. was supported by a Merck Investigator Studies Program grant that funded data collection in this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was obtained via the Research Ethics Committee of London School of Hygiene and Tropical Medicine on 7 April 2021 with reference 25637.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data and code used in this study are available at https://osf.io/c3esh. External data sources and pre-processing steps are outlined in Section 5 of the preregistered statistical analysis plan at https://osf.io/um2hd. https://osf.io/jmbkx/